GSK's Romanian unit tools up to make Seroxat, Retrovir; AZ to cease ops at U.K. plant;

 @FiercePharma: FDA staffers back Pfizer's Prevnar 13 vax for adults; advisory committee meets Wednesday. News | Follow @FiercePharma

> GlaxoSmithKline's ($GSK) Romanian unit is investing $7 million to add production lines to its plant in Brasov, to make way for manufacturing its antidepressant Seroxat and its HIV treatment Retrovir. Report

> AstraZeneca ($AZN) said operations at its plant in Loughborough, England, will cease at the end of the month as local officials seek a buyer or tenant for the 69-acre property. Story

> Increasing the dosage of the blood thinner Plavix in patients with a genetic variation improves response to the Sanofi/Bristol-Myers Squibb drug. Release

> United Drug is vying for contract packaging deals in Europe as outsourcing widens. News

> Vascular markers support lupus treatment. News

> GlaxoSmithKline ($GSK) is stirring up more opposition to its proposal for two wind turbines that would help power a plant in Scotland. Item

> Stevenson University bought a Shire Pharmaceuticals plant in Baltimore for $10.5 million to expand its campus. Story

> Exercise cuts breast cancer markers. News

> Pfizer ($PFE) has nabbed a site in Saudi Arabia for a new manufacturing facility to produce drugs for domestic and international markets. Piece

> Patients taking antidepressants and antipsychotic drugs have a higher risk of dying during a heart attack. Report

Biotech News

 @FierceBiotech: GSK's albiglutide flunks head-to-head diabetes PhIII with rival Victoza. Article | Follow @FierceBiotech

 @JohnCFierce: New PwC survey: Close to half of Americans didn't get care or take a drug due to out-of-pocket cost in last year. Release | Follow @JohnCFierce

 @RyanMFierce: Roche has tapped biotech Aileron for stapled peptide tech in inflammatory diseases, no financial details though. Release | Follow @RyanMFierce

 @MarkHFierce: Walgreens pharmacists and hospitals are teaching patients how to understand their new drugs before going home. Story | Follow @MarkHFierce

> Biotech VCs back startup Allena Pharma in $15M A round. News

> Gilead Sciences, J&J up the ante on new HIV drug combos. Story

Medical Device News

> Sera lands $19.3M, appoints Critchfield as CEO. More

> Study: Corus CAD demonstrates superiority to MPI. Item

> Accuray to cut 5% of workforce. Article

> Varian gains on word of Siemens' 'selective exit' from radiation therapy. News

Drug Delivery News

> Medgenics proceeds with biopump anemia treatment. Story

> Merck licenses Bend Research's spray-dried dispersion tech. Article

> New class of drugs may kill tumors by altering structure of crucial enzyme. More

> Cerulean Pharma enrolling for Phase 2 lung cancer trial. Piece

And Finally... U.S. patients who don't have insurance are discharged from the hospital sooner than those who are covered, a study found. Report

Suggested Articles

In a first, the FDA and Indian oversight agencies worked together to block illegal drugs from entering the U.S. 

The agency has granted Tecentriq a priority review in previously untreated NSCLC, setting up the Roche drug for an approval decision by June 19.

Warren Buffett's Berkshire Hathaway has built a $192 million stake in Biogen, a risky investment considering aducanumab's uncertain future.